IL164018A0 - Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa - Google Patents
Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xaInfo
- Publication number
- IL164018A0 IL164018A0 IL16401803A IL16401803A IL164018A0 IL 164018 A0 IL164018 A0 IL 164018A0 IL 16401803 A IL16401803 A IL 16401803A IL 16401803 A IL16401803 A IL 16401803A IL 164018 A0 IL164018 A0 IL 164018A0
- Authority
- IL
- Israel
- Prior art keywords
- factor
- inhibitors
- cyclopropylglycinyl
- serineprotease
- piperidin
- Prior art date
Links
- 108010074860 Factor Xa Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 229940123583 Factor Xa inhibitor Drugs 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052731 fluorine Chemical group 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36852302P | 2002-04-01 | 2002-04-01 | |
| PCT/US2003/007794 WO2003084929A1 (en) | 2002-04-01 | 2003-03-24 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL164018A0 true IL164018A0 (en) | 2005-12-18 |
Family
ID=28791889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16401803A IL164018A0 (en) | 2002-04-01 | 2003-03-24 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7166606B2 (enExample) |
| EP (1) | EP1492767B1 (enExample) |
| JP (1) | JP2005531529A (enExample) |
| KR (1) | KR20040094892A (enExample) |
| CN (1) | CN1288135C (enExample) |
| AT (1) | ATE303990T1 (enExample) |
| AU (1) | AU2003218147A1 (enExample) |
| BR (1) | BR0308870A (enExample) |
| CA (1) | CA2478340A1 (enExample) |
| CR (1) | CR7497A (enExample) |
| DE (1) | DE60301569T2 (enExample) |
| DK (1) | DK1492767T3 (enExample) |
| EA (1) | EA007300B1 (enExample) |
| EC (1) | ECSP045329A (enExample) |
| ES (1) | ES2248737T3 (enExample) |
| HR (1) | HRP20040900B1 (enExample) |
| IL (1) | IL164018A0 (enExample) |
| MX (1) | MXPA04009640A (enExample) |
| NO (1) | NO20044688L (enExample) |
| NZ (1) | NZ535402A (enExample) |
| PL (1) | PL373066A1 (enExample) |
| UA (1) | UA76849C2 (enExample) |
| WO (1) | WO2003084929A1 (enExample) |
| ZA (1) | ZA200407418B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6834308B1 (en) | 2000-02-17 | 2004-12-21 | Audible Magic Corporation | Method and apparatus for identifying media content presented on a media playing device |
| US7363278B2 (en) | 2001-04-05 | 2008-04-22 | Audible Magic Corporation | Copyright detection and protection system and method |
| US8972481B2 (en) | 2001-07-20 | 2015-03-03 | Audible Magic, Inc. | Playlist generation method and apparatus |
| DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
| EP3541381B1 (en) * | 2016-11-18 | 2022-12-28 | Merck Sharp & Dohme LLC | Inhibitors of factor xiia |
| EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69830410T2 (de) | 1997-08-29 | 2006-01-26 | Tularik Ltd. | Meta-benzamidinderivate als serinprotease-inhibitoren |
| ES2248084T3 (es) | 1999-06-14 | 2006-03-16 | Eli Lilly And Company | Inhibidores de serinproteasa. |
| WO2000076970A2 (en) | 1999-06-14 | 2000-12-21 | Eli Lilly And Company | Serine protease inhibitors |
| GB0030306D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030303D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030305D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030304D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| TWI257389B (en) | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
| WO2003010160A2 (en) * | 2001-07-26 | 2003-02-06 | Eli Lilly And Company | 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists |
-
2003
- 2003-03-24 AT AT03714138T patent/ATE303990T1/de not_active IP Right Cessation
- 2003-03-24 DE DE60301569T patent/DE60301569T2/de not_active Expired - Fee Related
- 2003-03-24 MX MXPA04009640A patent/MXPA04009640A/es active IP Right Grant
- 2003-03-24 WO PCT/US2003/007794 patent/WO2003084929A1/en not_active Ceased
- 2003-03-24 KR KR10-2004-7015486A patent/KR20040094892A/ko not_active Ceased
- 2003-03-24 HR HR20040900A patent/HRP20040900B1/xx not_active IP Right Cessation
- 2003-03-24 ES ES03714138T patent/ES2248737T3/es not_active Expired - Lifetime
- 2003-03-24 NZ NZ535402A patent/NZ535402A/en unknown
- 2003-03-24 PL PL03373066A patent/PL373066A1/xx unknown
- 2003-03-24 CA CA002478340A patent/CA2478340A1/en not_active Abandoned
- 2003-03-24 EA EA200401290A patent/EA007300B1/ru not_active IP Right Cessation
- 2003-03-24 JP JP2003582128A patent/JP2005531529A/ja active Pending
- 2003-03-24 BR BR0308870-7A patent/BR0308870A/pt not_active IP Right Cessation
- 2003-03-24 AU AU2003218147A patent/AU2003218147A1/en not_active Abandoned
- 2003-03-24 IL IL16401803A patent/IL164018A0/xx unknown
- 2003-03-24 EP EP03714138A patent/EP1492767B1/en not_active Expired - Lifetime
- 2003-03-24 UA UA20041008649A patent/UA76849C2/uk unknown
- 2003-03-24 CN CNB038074141A patent/CN1288135C/zh not_active Expired - Fee Related
- 2003-03-24 DK DK03714138T patent/DK1492767T3/da active
- 2003-03-24 US US10/486,138 patent/US7166606B2/en not_active Expired - Fee Related
-
2004
- 2004-09-15 ZA ZA200407418A patent/ZA200407418B/en unknown
- 2004-09-24 CR CR7497A patent/CR7497A/es unknown
- 2004-09-29 EC EC2004005329A patent/ECSP045329A/es unknown
- 2004-10-29 NO NO20044688A patent/NO20044688L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UA76849C2 (uk) | 2006-09-15 |
| CN1288135C (zh) | 2006-12-06 |
| CA2478340A1 (en) | 2003-10-16 |
| CN1642914A (zh) | 2005-07-20 |
| HRP20040900B1 (en) | 2006-02-28 |
| JP2005531529A (ja) | 2005-10-20 |
| BR0308870A (pt) | 2005-01-04 |
| ATE303990T1 (de) | 2005-09-15 |
| MXPA04009640A (es) | 2005-01-11 |
| DE60301569D1 (de) | 2005-10-13 |
| DE60301569T2 (de) | 2006-06-14 |
| AU2003218147A1 (en) | 2003-10-20 |
| WO2003084929A8 (en) | 2004-05-21 |
| CR7497A (es) | 2005-01-17 |
| ZA200407418B (en) | 2005-09-15 |
| HK1070363A1 (en) | 2005-06-17 |
| EP1492767A1 (en) | 2005-01-05 |
| NO20044688L (no) | 2004-10-29 |
| EA007300B1 (ru) | 2006-08-25 |
| US20050096328A1 (en) | 2005-05-05 |
| ES2248737T3 (es) | 2006-03-16 |
| NZ535402A (en) | 2006-02-24 |
| WO2003084929A1 (en) | 2003-10-16 |
| DK1492767T3 (da) | 2005-11-28 |
| HRP20040900A2 (en) | 2004-12-31 |
| EA200401290A1 (ru) | 2005-02-24 |
| PL373066A1 (en) | 2005-08-08 |
| EP1492767B1 (en) | 2005-09-07 |
| ECSP045329A (es) | 2004-11-26 |
| US7166606B2 (en) | 2007-01-23 |
| KR20040094892A (ko) | 2004-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2416B (is) | Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar | |
| IS6902A (is) | N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl | |
| NO20054852L (no) | GFAT inhibitorer | |
| IL164511A0 (en) | Heterocyclic compounds | |
| NO20061454L (no) | Compounds having CRTH2 antagonist activity | |
| MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
| MY136883A (en) | 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| EA200600223A1 (ru) | Замещённый 2-аминотетралины для лечения депрессии | |
| MX2009002229A (es) | Benzotriazoles como moduladores de cinasas. | |
| PL362834A1 (en) | Phenyl derivatives | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| GB0426313D0 (en) | Therapeutic agents | |
| NO20062256L (no) | Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner | |
| NO20070089L (no) | DPP-IV inhibitorer | |
| DE602004018811D1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| IL164018A0 (en) | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa | |
| MXPA03010205A (es) | Derivados de acido oxalico. | |
| MY137876A (en) | Pharmaceutical compound | |
| MXPA05006957A (es) | Nuevos derivados de fosforamida. | |
| WO2003076429A3 (en) | Azepane derivatives and their use as atk1 inhibitors | |
| AU2002322396A1 (en) | 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists | |
| TW200603806A (en) | Pharmaceutical compound | |
| SI1492767T1 (sl) | Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze | |
| AU2002366563A1 (en) | Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders | |
| TW200621720A (en) | Crystalline forms of a factor xa inhibitor |